EA201591230A1 - Композиция диклофенака - Google Patents

Композиция диклофенака

Info

Publication number
EA201591230A1
EA201591230A1 EA201591230A EA201591230A EA201591230A1 EA 201591230 A1 EA201591230 A1 EA 201591230A1 EA 201591230 A EA201591230 A EA 201591230A EA 201591230 A EA201591230 A EA 201591230A EA 201591230 A1 EA201591230 A1 EA 201591230A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
diclofenac
present
relates
administration
Prior art date
Application number
EA201591230A
Other languages
English (en)
Other versions
EA035079B1 (ru
Inventor
Динеш Шантилал Пател
Сачин Динеш Пател
Шашикант Прабхудас Курани
Мадхавлал Говиндлал Пател
Original Assignee
Темис Медикэр Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54198802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201591230(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Темис Медикэр Лимитед filed Critical Темис Медикэр Лимитед
Publication of EA201591230A1 publication Critical patent/EA201591230A1/ru
Publication of EA035079B1 publication Critical patent/EA035079B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Abstract

Настоящее изобретение относится к композиции, содержащей диклофенак и его соли, где диклофенак или его соли присутствуют в количестве 25-200 мг. Композиция является применимой для парентерального введения посредством внутримышечного, внутривенного пути введения; а также для перорального, кожного, подкожного, назального введения в виде глазных капель, в виде ректальных суппозиториев, вагинальных суппозиториев, для внутрисуставной и ушной доставки. Настоящее изобретение относится также к композициям, содержащим комбинацию диклофенака и других лекарственных средств. Изобретение далее относится к способу получения указанной композиции.
EA201591230A 2012-12-28 2013-12-27 Композиция диклофенака EA035079B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3704MU2012 2012-12-28
PCT/IN2013/000805 WO2014102824A1 (en) 2012-12-28 2013-12-27 Diclofenac composition

Publications (2)

Publication Number Publication Date
EA201591230A1 true EA201591230A1 (ru) 2015-11-30
EA035079B1 EA035079B1 (ru) 2020-04-24

Family

ID=54198802

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591230A EA035079B1 (ru) 2012-12-28 2013-12-27 Композиция диклофенака

Country Status (25)

Country Link
US (1) US20140187635A1 (ru)
EP (1) EP2938325B8 (ru)
JP (1) JP6117939B2 (ru)
KR (1) KR101730284B1 (ru)
CN (1) CN104968331A (ru)
AP (1) AP2015008534A0 (ru)
AU (1) AU2013368849B2 (ru)
BR (1) BR112015015699B1 (ru)
CL (1) CL2015001869A1 (ru)
EA (1) EA035079B1 (ru)
ES (1) ES2721400T3 (ru)
HK (1) HK1211858A1 (ru)
HU (1) HUE045030T2 (ru)
IL (1) IL239395A0 (ru)
MA (1) MA38292A1 (ru)
MX (1) MX365375B (ru)
MY (1) MY184886A (ru)
PE (1) PE20151208A1 (ru)
PH (1) PH12015501479B1 (ru)
SG (1) SG11201504577UA (ru)
SI (1) SI2938325T1 (ru)
TR (1) TR201905806T4 (ru)
UA (1) UA114123C2 (ru)
WO (1) WO2014102824A1 (ru)
ZA (1) ZA201504258B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
GR1009729B (el) * 2018-08-02 2020-05-15 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια Σταθερος ενεσιμος συνδυασμος
ES2964698T3 (es) * 2018-11-16 2024-04-09 Seikagaku Kogyo Co Ltd Composición farmacéutica
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
WO2021144476A1 (en) * 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
WO1993000895A1 (en) * 1991-07-04 1993-01-21 Taisho Pharmaceutical Co., Ltd. Analgesic
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
EP1605900A4 (en) * 2003-03-26 2007-10-17 Becton Dickinson Co USE OF BENZYL ALCOHOL AND OTHER PHENOLIC PRESERVATIVE SUBSTANCES TO REDUCE PAIN IN INTRADERMAL INJECTION
US20050137164A1 (en) * 2003-09-22 2005-06-23 Moshe Arkin Diclofenac compositions for the treatment of skin disorders
ES2287658T3 (es) 2004-03-10 2007-12-16 Shimoda Biotech (Pty) Ltd Composiciones inyectables estables de diclofenac.
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
WO2006095363A2 (en) * 2005-02-01 2006-09-14 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenic and its pharmaceutically acceptable salts
CN101217939A (zh) * 2005-05-27 2008-07-09 灵药生物技术有限公司 可注射组合物及制备这类组合物的方法
CN102227211A (zh) 2008-11-28 2011-10-26 先进控股有限公司 包含双氯芬酸和羟基脂肪酸聚氧化烯烃酯的药物配制剂

Also Published As

Publication number Publication date
SG11201504577UA (en) 2015-07-30
CN104968331A (zh) 2015-10-07
HK1211858A1 (en) 2016-06-03
KR20150090250A (ko) 2015-08-05
ZA201504258B (en) 2016-04-28
CL2015001869A1 (es) 2015-10-23
US20140187635A1 (en) 2014-07-03
PH12015501479A1 (en) 2015-09-21
PE20151208A1 (es) 2015-08-23
MX2015008369A (es) 2016-03-01
UA114123C2 (xx) 2017-04-25
IL239395A0 (en) 2015-07-30
ES2721400T8 (es) 2019-10-10
AU2013368849A1 (en) 2015-07-09
SI2938325T1 (sl) 2019-06-28
AP2015008534A0 (en) 2015-06-30
EP2938325A1 (en) 2015-11-04
HUE045030T2 (hu) 2019-12-30
WO2014102824A1 (en) 2014-07-03
BR112015015699A2 (pt) 2017-07-11
JP6117939B2 (ja) 2017-04-19
TR201905806T4 (tr) 2019-05-21
EA035079B1 (ru) 2020-04-24
BR112015015699B1 (pt) 2022-09-27
JP2016508139A (ja) 2016-03-17
EP2938325B1 (en) 2019-04-10
EP2938325B8 (en) 2019-09-25
MX365375B (es) 2019-05-31
AU2013368849B2 (en) 2017-01-12
ES2721400T3 (es) 2019-07-31
MY184886A (en) 2021-04-29
WO2014102824A8 (en) 2014-10-02
MA38292A1 (fr) 2017-06-30
PH12015501479B1 (en) 2015-09-21
KR101730284B1 (ko) 2017-04-25

Similar Documents

Publication Publication Date Title
EA201591230A1 (ru) Композиция диклофенака
MY175318A (en) Androgen composition for treating an opthalmic condition
MX2020008468A (es) Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
EA202190619A1 (ru) Противовирусные соединения
IN2014MN02598A (ru)
BR112014031806A8 (pt) método para tratamento de câncer positivo para gd2
PH12014501417A1 (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
PE20141553A1 (es) Compuestos de triazolopiridina como inhibidores de la ped10a
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
MY171201A (en) New carbamate glycolipid and use thereof
EA201391056A1 (ru) Гетероарильные соединения в качестве лигандов 5-htрецептора
MX2015008187A (es) Inhibidores de alk deuterados.
MY160383A (en) Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
EA201391124A1 (ru) Новые бензодиоксолпиперазиновые соединения
IN2014DN03245A (ru)
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
EA201490233A8 (ru) Стабильные лекарственные формы артеролана и пиперахина
EA201390327A1 (ru) Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
MX2013011728A (es) Nuevos compuestos de benzofurano-piperidina.
TN2013000081A1 (en) Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
CU20140150A7 (es) Proceso para producir solución de acetaminofén supersaturada inyectable de administración por la espina dorsal
BR112014003100A2 (pt) emprego de mad2l2 como um marcador de estratificação no tratamento de tumores de mama com novos inibidores pan-cdk

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM